Autism Spectrum Disorder (ASD)
Neurology·MeSH: Autism Spectrum Disorder
Prevalence
0.1 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| pax-101 | Kuvatris Therapeutics, Inc. (PXMD) |
Frequently asked questions
How many drugs are in development for Autism Spectrum Disorder (ASD)?
BioSniper tracks 1 drug in development for Autism Spectrum Disorder (ASD) across 1 company.
How many clinical trials target Autism Spectrum Disorder (ASD)?
There are 2 clinical trials targeting Autism Spectrum Disorder (ASD) tracked by BioSniper.
What is the prevalence of Autism Spectrum Disorder (ASD)?
The estimated prevalence of Autism Spectrum Disorder (ASD) is approximately 0.1 per 100,000 population.
Deep-dive into Autism Spectrum Disorder (ASD)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis